3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
7
Triple Negative Breast Neoplasms
2
Solid Tumors
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HER2-positive Breast Cancer
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
enzalutamide
4
abiraterone
2
sapanisertib
1
onvansertib
1
inavolisib
1
abemaciclib
1
Prednisone
1
Docetaxel
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Metastatic Castration-Resistant Prostate Cancer
×
inavolisib
×
Clear all
NCT07287150
2026-05-06
InavoPC
Hoffmann-La Roche
Phase 2
Recruiting
100 enrolled